Read + Share
Haga Y, Meyer K, Sung MMH, Reagan EK, et al. Hepatitis C virus modified sE2(F442NYT) as an antigen in candidate vaccine
facilitates human immune cell activation. J Virol 2023 Dec 12:e0180923. doi: 10.1128/jvi.01809.
PMID: 38084956
|
 |
|
Haga Y, Meyer K, Sung MMH, Reagan EK, et al. Hepatitis C virus modified sE2(F442NYT) as an antigen in candidate vaccine
facilitates human immune cell activation. J Virol 2023 Dec 12:e0180923. doi: 10.1128/jvi.01809.
PMID: 38084956
|
|
|
|